Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Helsinn Healthcare SA
Helsinn Healthcare SA
Eli Lilly and Company
The Hospital for Sick Children
University Hospital Freiburg
Helsinn Healthcare SA
Duke University
University of Auckland, New Zealand
ChineseAMS
Rafa Laboratories
ChineseAMS
Henan Cancer Hospital
Consorzio Oncotech
Khon Kaen University
Wake Forest University Health Sciences
Duke University
St. Louis University
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
University of Washington
University of Michigan Rogel Cancer Center
Swedish Medical Center
Mashhad University of Medical Sciences
Hoosier Cancer Research Network
Zhejiang University
University of Rochester
M.D. Anderson Cancer Center
State University of New York - Upstate Medical University
Clinica Universidad de Navarra, Universidad de Navarra
The Catholic University of Korea
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
University of Manitoba
University of South Florida
Bharath Charitable Cancer Hospital and Institute
Fudan University
Samsung Medical Center
M.D. Anderson Cancer Center
Ono Pharmaceutical Co. Ltd
Northwestern University
Hallym University Medical Center
New Mexico Cancer Research Alliance
GlaxoSmithKline
Gruppo Italiano Studio Linfomi
Xijing Hospital